PTEN expression was lower, the PI3K/AKT pathway was overactivated, and the levels of fibrosis markers were upregulated in the LV − miR − 214 − OE + BC group (Figures 5(a) – 5(e)). The gene discussed is AKT1; the disease is breast cancer.